Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Rici Healthcare Holdings Limited (1526.HK)
HKD1.13
-0.09 (-7.38%)
CN HKSE Healthcare Medical - Care Facilities
Address
Building 1 200126
Shanghai, CN
Shanghai, CN
CEO
Yixin Fang
Website
rich-healthcare.com
IPO
2016-10-06
ISIN KYG755601054
Description
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examination centers. By the close of 2021, specifically December 31st, the company's network included 68 medical examination centers. Beyond these core activities, Rici Healthcare also offers health advisory services, nursing care, diagnostic testing, and leasing arrangements. The firm was established in 2000 and has its principal corporate office located in Shanghai, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
HKD1.13
-0.09 (-7.38%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
397.5K
Beta
0.69
Float Shares
618.94M
Free Float %
38.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.63% | +10.29% | -9.64% | -22.68% | -27.18% | -33.04% | -29.25% | -18.48% | -38.52% | -68.22% | -68.22% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.13
DCF (Unlevered)
6.22
+450.3%
DCF (Levered)
10.12
+795.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.06
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
3 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-4.4% Q4'25: -3.4% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+0.0% Q4'25: +6.7% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+11.7% Q4'25: +24.9% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+24.3% ★ Q4'25: +31.0% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+18.0% ★ Q4'25: +54.3% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.28× ★ Q4'25: 0.82× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2020 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
935.38M
est: 992.94M (-5.8%)
|
935.38M
est: 1.11B (-15.6%)
|
1.08B
est: 1.16B (-7.0%)
|
1.08B
est: 1.38B (-21.6%)
|
1.37B
est: 1.44B (-4.9%)
|
1.37B
est: 1.73B (-20.4%)
|
1.73B
est: 2.17B (-20.3%)
|
1.73B
est: 2.46B (-29.8%)
|
1.93B
est: 3.11B (-38.1%)
|
1.93B
est: 3.70B (-47.9%)
|
2.92B
est: 1.11B (+163.8%)
|
2.80B
est: 1.38B (+103.0%)
|
1.73B
1.73B – 1.73B
+25.3% YoY
|
2.46B
2.46B – 2.46B
+42.4% YoY
|
3.70B
3.70B – 3.70B
+50.4% YoY
|
| EBITDA |
171.04M
est: 254.35M (-32.8%)
|
171.04M
est: 341.81M (-50.0%)
|
2.21M
est: 172.07M (-98.7%)
|
2.21M
est: 172.07M (-98.7%)
|
-33.14M
est: 370.11M (-109.0%)
|
-33.14M
est: 532.33M (-106.2%)
|
347.11M
est: 554.73M (-37.4%)
|
347.11M
est: 758.08M (-54.2%)
|
234.75M
est: 796.98M (-70.5%)
|
234.75M
est: 1.14B (-79.4%)
|
798.69M
est: 327.04M (+144.2%)
|
883.88M
est: 406.33M (+117.5%)
|
509.32M
509.32M – 509.32M
+25.3% YoY
|
725.31M
725.31M – 725.31M
+42.4% YoY
|
1.09B
1.09B – 1.09B
+50.4% YoY
|
| EBIT |
90.99M
est: 174.66M (-47.9%)
|
90.99M
est: 237.86M (-61.7%)
|
-83.67M
est: 87.82M (-195.3%)
|
-83.67M
est: 87.82M (-195.3%)
|
-133.75M
est: 254.15M (-152.6%)
|
-133.75M
est: 370.43M (-136.1%)
|
-8.90M
est: 380.93M (-102.3%)
|
-8.90M
est: 527.52M (-101.7%)
|
76.36M
est: 547.29M (-86.0%)
|
76.36M
est: 793.43M (-90.4%)
|
626.24M
est: 240.11M (+160.8%)
|
679.61M
est: 298.33M (+127.8%)
|
373.94M
373.94M – 373.94M
+25.3% YoY
|
532.52M
532.52M – 532.52M
+42.4% YoY
|
800.95M
800.95M – 800.95M
+50.4% YoY
|
| Net Income |
58.92M
est: 65.06M (-9.4%)
|
58.92M
est: 65.06M (-9.4%)
|
-62.17M
est: 57.26M (-208.6%)
|
-62.17M
est: 57.26M (-208.6%)
|
-53.84M
est: -56.39M (+4.5%)
|
-53.84M
est: -59.12M (+8.9%)
|
-69.16M
est: 80.97M (-185.4%)
|
-69.16M
est: 80.97M (-185.4%)
|
-7.88M
est: 253.91M (-103.1%)
|
-7.88M
est: 253.91M (-103.1%)
|
297.32M
est: 68.22M (+335.8%)
|
307.13M
est: -50.30M (+710.6%)
|
-60.53M
-60.53M – -60.53M
-20.3% YoY
|
82.57M
82.57M – 82.57M
+236.4% YoY
|
271.07M
271.07M – 271.07M
+228.3% YoY
|
| SGA |
277.13M
est: 214.12M (+29.4%)
|
277.13M
est: 222.51M (+24.5%)
|
468.14M
est: 261.33M (+79.1%)
|
468.14M
est: 261.33M (+79.1%)
|
553.93M
est: 311.57M (+77.8%)
|
553.93M
est: 346.53M (+59.8%)
|
543.02M
est: 466.99M (+16.3%)
|
543.02M
est: 493.49M (+10.0%)
|
519.13M
est: 670.92M (-22.6%)
|
519.13M
est: 742.24M (-30.1%)
|
566.99M
est: 222.36M (+155.0%)
|
543.23M
est: 276.26M (+96.6%)
|
346.29M
346.29M – 346.29M
+25.3% YoY
|
493.14M
493.14M – 493.14M
+42.4% YoY
|
741.72M
741.72M – 741.72M
+50.4% YoY
|
| EPS |
0.04
est: 0.04 (+6.8%)
|
0.04
est: 0.04 (+6.8%)
|
-0.04
est: -0.03 (-31.3%)
|
-0.04
est: -0.03 (-31.3%)
|
-0.03
est: -0.04 (+4.7%)
|
-0.03
est: -0.04 (+9.1%)
|
-0.04
est: 0.05 (-185.4%)
|
-0.04
est: 0.05 (-185.4%)
|
-0.01
est: 0.16 (-103.1%)
|
-0.01
est: 0.16 (-103.1%)
|
0.19
est: 0.04 (+342.9%)
|
0.19
est: -0.03 (+700.7%)
|
-0.04
-0.04 – -0.04
-20.3% YoY
|
0.05
0.05 – 0.05
+236.4% YoY
|
0.17
0.17 – 0.17
+228.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
930.21M
OE per share TTM
0.58
Owner's Yield
77.99%
Maintenance CapEx ratio
2,825.21%
Maint CapEx / Avg PPE
111.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
76.3K
Shares Outstanding
1.59B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hong Mei | Vice President & Executive Director | 1M | — |
| Xiaoying Lin | Chief Operating Officer, Executive Vice President, GM of Human Resources Center & Executive Director | 995.0K | female |
| Haoze Fang | Executive Vice President, GM of Medical Examination Business Department & Executive Director | 635.6K | male |
| Yixin Fang | Founder, Executive Chairman & Chief Executive Officer | 606.7K | — |
| Li Zhu | Chief Legal Officer | — | male |
| Kun Chen | Company Secretary | — | male |
| Hang Siu Lee | Company Secretary | — | female |
| Yan Wang | Chief Financial Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1526.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
